Canada - TSX-V:NSCI - CA63000Y1034 - Common Stock
The current stock price of NSCI.CA is 0.19 CAD. In the past month the price decreased by -11.63%. In the past year, price decreased by -48.65%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 252.10M | ||
| MIR.CA | MEDMIRA INC | N/A | 60.66M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 49.56M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 46.82M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 27.32M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 24.32M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.53M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 16.77M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 3.98M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K | ||
| VVTM.CA | VVT MED INC | N/A | 20.05M |
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. Its segments include Scientific Equipment and Security Services. The Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology company that develops, manufactures, and sells magnetic resonance (MR) products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science and medical applications. The Security Services segment focuses on providing security services, namely providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. The firm's devices are used in industries, including chemical, mining, pharma, and others.
NANALYSIS SCIENTIFIC CORP
Unit 105, 90 Freeport Boulevard NE
Calgary ALBERTA T2E 7C3 CA
CEO: Sean Krakiwsky
Employees: 249
Phone: 14037699499
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. Its segments include Scientific Equipment and Security Services. The Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology company that develops, manufactures, and sells magnetic resonance (MR) products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science and medical applications. The Security Services segment focuses on providing security services, namely providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. Within the Company's Security Services business, the core activity is providing airport security equipment maintenance in each province and territory of Canada. The firm's devices are used in industries, including chemical, mining, pharma, and others.
The current stock price of NSCI.CA is 0.19 CAD. The price increased by 5.56% in the last trading session.
NSCI.CA does not pay a dividend.
NSCI.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
5 analysts have analysed NSCI.CA and the average price target is 0.84 CAD. This implies a price increase of 342.89% is expected in the next year compared to the current price of 0.19.
The Revenue of NANALYSIS SCIENTIFIC CORP (NSCI.CA) is expected to decline by -0.13% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
NANALYSIS SCIENTIFIC CORP (NSCI.CA) will report earnings on 2025-11-27.
ChartMill assigns a fundamental rating of 4 / 10 to NSCI.CA. Both the profitability and financial health of NSCI.CA have multiple concerns.
Over the last trailing twelve months NSCI.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 13.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.34% | ||
| ROE | -99.08% | ||
| Debt/Equity | 0.72 |
5 analysts have analysed NSCI.CA and the average price target is 0.84 CAD. This implies a price increase of 342.89% is expected in the next year compared to the current price of 0.19.
For the next year, analysts expect an EPS growth of 81.82% and a revenue growth -0.13% for NSCI.CA